Scynexis (SCYX) Return on Invested Capital (2019 - 2023)

Scynexis (SCYX) posted Return on Invested Capital of 0.02% for Q4 2023, up 3.79% on a QoQ basis from 0.02% in Q3 2023.

Scynexis (SCYX) Return on Invested Capital (2019 - 2023) Analysis & Trends

Scynexis' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.02% for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	0.01%
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	0.01%
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	0.00%
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	0.00%
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	0.03%
10	Scynexis	21.55 Mn	-15.20 Mn	-	-

Download Data